DSP-5423P

· Sumitomo Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DSP-5423P, covering 2020-11-19 to 2020-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study of DSP-5423P in Patients With Schizophrenia [Phase 3]